Hormonal Therapy Patterns in Older Men with Prostate Cancer in the United States, 2010–2019
The increasing use of adjuvant HT in higher-risk PCa patients aligns with evolving treatment guidelines, while the stable rate of primary HT in lower-risk patients represents persistent inappropriate use and highlights the need for further efforts to optimize treatment choices. While previous studies focused on men with intermediate-risk PCa receiving radiation therapy, our study broadens the scope to include men who did not undergo radiation therapy, providing a more inclusive view of HT trends. Future research should focus on refining strategies to reduce inappropriate primary HT use and improve adjuvant HT administration.
Authors
- Jacques Baillargeon (ORCID: https://orcid.org/0000-0002-3297-653X)
- Yong‐Fang Kuo (ORCID: https://orcid.org/0000-0003-1927-0927)
- Randall J. Urban (ORCID: https://orcid.org/0000-0002-6492-2042)
- David S. López (ORCID: https://orcid.org/0000-0002-2321-0372)
- Mohanad Albayyaa (ORCID: https://orcid.org/0000-0003-4185-5294)
- Biai Dominique Elmir Digbeu (ORCID: https://orcid.org/0000-0001-8741-9506)
- Vahakn B. Shahinian (ORCID: https://orcid.org/0000-0003-3280-7821)
Institutions
- Baylor University (US)
- University of Michigan (US)
- John Sealy Hospital (US)
- Michigan Medicine (US)
- The University of Texas Medical Branch at Galveston (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-04
- DOI
- https://doi.org/10.3390/cancers17193231
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Prevention and Research Institute of Texas
- California Department of Public Health
- University of Southern California
- Centers for Disease Control and Prevention
- Agency for Healthcare Research and Quality
- University of California, San Francisco
- National Cancer Institute